Molina Healthcare (MOH) has experienced a significant drop in its share price, with a one-year fall of 56% and 48.8%. The company's valuation is revisited after the price drop, Q4 earnings, and mixed results. Major share purchases were made by Royce & Associates LP, Strive Asset Management LLC, AustralianSuper Pty Ltd, Victory Capital Management Inc., and James Woys, among others. However, MOH's Q4 results were a sticking point, causing share prices to nosedive and calling into question Medicaid profitability as an investment mover. Negative reception to their 2026 guidance also led to a stock price plunge. There have also been notable insider buys, including those from Mark Lowell Keim, Debra Bacon, Jeff D Barlow, and Chief Accounting Officer. The lowered price target by Morgan Stanley and Goldman Sachs paints a bearish outlook and invokes question about MOH's cost assumption credibility among investors. Questions linger about mixed Q4 results and legal scrutiny on MOH's valuation. To reassure investors, MOH reaffirms its 2026 earnings guidance.
Molina Healthcare MOH News Analytics from Mon, 20 Oct 2025 07:00:00 GMT to Sat, 07 Mar 2026 22:32:35 GMT -
Rating -6
- Innovation -2
- Information 0
- Rumor -2
